<DOC>
	<DOCNO>NCT03086824</DOCNO>
	<brief_summary>The purpose study investigate safety effectiveness subject receive MR-guided Focused Ultrasound ( MRgFUS ) treatment painful bone metastasis . This study evaluate treatment response clinically significant adverse event . Other relevant data may document well .</brief_summary>
	<brief_title>A Safety Evaluation MR-guided Focused Ultrasound Treatment Palliative Pain Control Bone Metastases</brief_title>
	<detailed_description>This propose study perform full compliance applicable privacy rule regulation , implementation participate site ( ) . All subject plan undergo MRgFUS procedure Taipei Medical University Hospital offer informed consent include Study .</detailed_description>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<criteria>1 . Men woman age 20 old . 2 . Patients able willing give consent able attend study visit . 3 . Patients suffer symptom bone metastasis : Patients receive radiation without adequate relief metastatic bone pain determine patient treat physician , treat physician would prescribe radiation additional radiation treatment , patient refuse additional radiation therapy . 4 . Patient NRS ( 010 scale ) pain score ≥ 4 irrespective medication . 5 . Targeted bone/tumor interface ExAblate device accessible locate rib , extremity ( exclude joint ) , pelvis , shoulder posterior aspect follow spinal vertebra : Lumbar vertebra ( L3L5 ) , Sacral vertebra ( S1S5 ) . 6 . Patient whose targeted lesion bone interface bone lesion deeper 10mm skin . 7 . Targeted ( treat ) tumor clearly visible noncontrast MRI , ExAblate MRgFUS device accessible . 8 . Patients ongoing chemotherapy regimen time eligibility : 1 ) chemotherapy regimen ( document patient medical dossier , 2 ) bad pain NRS still ≥ 4 , 3 ) NOT plan initiate new chemotherapy pain palliation eligible study . Note : Planned multiple course chemotherapy consider New Chemotherapy . 9 . No radiation therapy target ( painful ) lesion past two week . 10 . Bisphosphonate intake remain stable throughout study duration . 1 . Patients either Need surgical stabilization affect bony structure Targeted tumor impend fracture site Surgical stabilization tumor site metallic hardware . 2 . KPS ( Karnofsky performance scale ) Score &lt; 60 . 3 . Unable communicate sensation ExAblate treatment . 4 . Target ( treat ) tumor le 10mm nerve bundle , bowel bladder . 5 . Patients acute medical condition ( e.g. , pneumonia , sepsis ) expect hinder complete study . 6 . Severe cerebrovascular disease ( multiple CVA CVA within 6 month ) . 7 . Patients unstable cardiac status ( e.g . unstable angina pectoris , myocardial infarction within 6 month , congestive heart failure NYHA Class IV , arrhythmic drug ) . 8 . Severe hypertension ( diastolic BP &gt; 100 mmHg medication ) . 9 . Patients dialysis . 10 . Patients standard contraindication MRI MRI contrast agent .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Bone Metastasis</keyword>
</DOC>